Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer Jietao MaJun SongChengbo Han Research Open access 10 February 2024 Article: 40
Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer Qin ZhuYukun CaoYu Hu Research Open access 31 January 2024 Article: 39
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data Takafumi YanagisawaKeiichiro MoriTakahiro Kimura Review Open access 30 January 2024 Article: 38
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy Yuejun LuoChengming LiuJie He Research Open access 28 January 2024 Article: 37
CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors Jianghua WangXiaoting LiBaiyong Li Research Open access 27 January 2024 Article: 36
Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome Debin ChengZhao ZhangHongbin Fan Research Open access 27 January 2024 Article: 35
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells Mikel Gurrea-RubioQi WuDavid A. Fox Research Open access 27 January 2024 Article: 34
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram Xiaomei ZhangRui SunMingfeng Zhao Research Open access 27 January 2024 Article: 33
The complex role of IL-10 in malignant ascites: a review Yue HuangKangni ZouZhengyu Li Review Open access 27 January 2024 Article: 32
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions Xingchen LiWenzhi TianJifeng Yu Review Open access 27 January 2024 Article: 31
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo Iga JancewiczMagdalena ŚmiechPawel Wisniewski Research Open access 27 January 2024 Article: 30
Presence of Epstein–Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma T. MangiaterraR. Alonso-AlonsoP. Chabay Research Open access 27 January 2024 Article: 29
Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma J. M. VersluisE. P. HoefsmitC. U. Blank Research Open access 27 January 2024 Article: 28
Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates Andrea N. MazzarelloElena GugiattiSilvia Bruno Research Open access 27 January 2024 Article: 27
Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer Xiuhua LinShichuan TangBaosong Xie Research Open access 27 January 2024 Article: 26
Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation Alina D. NikotinaSnezhana A. VladimirovaIrina V. Guzhova Research Open access 27 January 2024 Article: 25
Characterization of T cell receptor repertoire in penile cancer Junying ZhangYapeng WangWeihua Lan Research Open access 27 January 2024 Article: 24
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer Koji OtsukaJunya IsobeKiyoshi Yoshimura Research Open access 27 January 2024 Article: 23
An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome Patricio YankilevichLoulieta NazeraiMorten Nielsen Research Open access 27 January 2024 Article: 22
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy Amit SharmaXiubao RenIngo G. H. Schmidt-Wolf Meeting Report Open access 27 January 2024 Article: 21